Literature DB >> 23998385

COPD in chronic heart failure: less common than previously thought?

Armine G Minasian1, Frank J J van den Elshout, P N Richard Dekhuijzen, Petra J E Vos, Frank F Willems, Paul J P C van den Bergh, Yvonne F Heijdra.   

Abstract

BACKGROUND: Using a fixed ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC) < 0.70 instead of the lower limit of normal (LLN) to define chronic obstructive pulmonary disease (COPD) may lead to overdiagnosis of COPD in elderly patients with heart failure (HF) and consequently unnecessary treatment with possible adverse health effects.
OBJECTIVE: The aim of this study was to determine COPD prevalence in patients with chronic HF according to two definitions of airflow obstruction.
METHODS: Spirometry was performed in 187 outpatients with stable chronic HF without pulmonary congestion who had a left ventricular ejection fraction <40% (mean age 69 ± 10 years, 78% men). COPD diagnosis was confirmed 3 months after standard treatment with tiotropium in newly diagnosed COPD patients.
RESULTS: COPD prevalence varied substantially between 19.8% (LLN-COPD) and 32.1% (GOLD-COPD). Twenty-three of 60 patients (38.3%) with GOLD-COPD were potentially misclassified as having COPD (FEV1/FVC < 0.7 but > LLN). In contrast to patients with LLN-COPD, potentially misclassified patients did not differ significantly from those without COPD regarding respiratory symptoms and risk factors for COPD.
CONCLUSIONS: One fifth, rather than one third, of the patients with chronic HF had concomitant COPD using the LLN instead of the fixed ratio. LLN may identify clinically more important COPD than a fixed ratio of 0.7.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABHR; ACE-I; ARB; ATS/ERS; American Thoracic Society/European Respiratory Society; BMI; CABG; COPD; CRT; CS; Chronic heart failure; Chronic obstructive pulmonary disease; FEV(1)/FVC; FS; Fixed ratio; GOLD; Global Initiative for Chronic Obstructive Lung Disease; HF; ICD; LLN; LVEF; LVSD; Lower limit of normal; MLHFQ; MRC; Minnesota Living with Heart Failure Questionnaire; N-terminal pro-B natriuretic peptide; NS; NT-pro-BNP; NYHA; New York Heart Association; PCI; PFT; PY; Prevalence; angiotensin receptor blocker; angiotensin-converting enzyme inhibitor; aspecific bronchial hyperreactivity; body mass index; cardiac resynchronization therapy; chronic obstructive pulmonary disease; coronary artery bypass grafting; current smokers; former smokers; heart failure; implantable cardioverter defibrillator; left ventricular ejection fraction; left ventricular systolic dysfunction; lower limit of normal; modified Medical Research Council dyspnea scale; non-smokers; pack-years; percutaneous coronary intervention; pulmonary function tests; ratio of forced expiratory volume in 1 s to forced vital capacity

Mesh:

Year:  2013        PMID: 23998385     DOI: 10.1016/j.hrtlng.2013.07.002

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  10 in total

Review 1.  Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.

Authors:  Gülmisal Güder; Frans H Rutten
Journal:  Curr Heart Fail Rep       Date:  2014-09

2.  The 'missing millions': Where do we find them?

Authors:  Nawar Diar Bakerly; Glenn Cardwell
Journal:  Chron Respir Dis       Date:  2016-11       Impact factor: 2.444

3.  Long-Term Outpatient Care and Rehospitalizations in Patients after Cardiac Electrotherapy Device Implantation.

Authors:  Roman Załuska; Anna Milewska; Anastasius Moumtzoglou; Marcin Grabowski; Wojciech Drygas
Journal:  Medicina (Kaunas)       Date:  2022-01-19       Impact factor: 2.430

4.  The prognostic significance of lung function in stable heart failure outpatients.

Authors:  Louis Lind Plesner; Morten Dalsgaard; Morten Schou; Lars Køber; Jørgen Vestbo; Erik Kjøller; Kasper Iversen
Journal:  Clin Cardiol       Date:  2017-09-13       Impact factor: 2.882

5.  Prevalence of airflow obstruction in patients with stable systolic heart failure.

Authors:  Morten Dalsgaard; Louis Lind Plesner; Morten Schou; Erik Kjøller; Jørgen Vestbo; Kasper Iversen
Journal:  BMC Pulm Med       Date:  2017-01-06       Impact factor: 3.317

6.  Use of the terms "overdiagnosis" and "misdiagnosis" in the COPD literature: a rapid review.

Authors:  Elizabeth T Thomas; Paul Glasziou; Claudia C Dobler
Journal:  Breathe (Sheff)       Date:  2019-03

7.  Restrictive Spirometry Pattern, Cardiac Structure and Function, and Incident Heart Failure in African Americans. The Jackson Heart Study.

Authors:  Matthew Jankowich; Beth Elston; Qing Liu; Siddique Abbasi; Wen-Chih Wu; Chad Blackshear; Mark Godfrey; Gaurav Choudhary
Journal:  Ann Am Thorac Soc       Date:  2018-10

8.  Serial pulmonary function tests to diagnose COPD in chronic heart failure.

Authors:  Armine G Minasian; Frank Jj van den Elshout; Pn Richard Dekhuijzen; Petra Je Vos; Frank F Willems; Paul Jpc van den Bergh; Yvonne F Heijdra
Journal:  Transl Respir Med       Date:  2014-09-25

9.  Heart failure and levels of other comorbidities in patients with chronic obstructive pulmonary disease in a Swedish population: a register-based study.

Authors:  Elzbieta Kaszuba; Håkan Odeberg; Lennart Råstam; Anders Halling
Journal:  BMC Res Notes       Date:  2016-04-12

10.  Modeling indoor TV/screen viewing and adult physical and mental health: Health Survey for England, 2012.

Authors:  Ivy Shiue
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-05       Impact factor: 4.223

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.